Compare IXHL & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IXHL | TPCS |
|---|---|---|
| Founded | 2001 | 1956 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | | Metal Fabrications |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.0M | 45.1M |
| IPO Year | 2024 | 2008 |
| Metric | IXHL | TPCS |
|---|---|---|
| Price | $3.43 | $5.26 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 79.3K | 23.6K |
| Earning Date | 05-15-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 41.38 |
| EPS | N/A | ★ N/A |
| Revenue | $12,000.00 | ★ $31,644,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.16 | $2.88 |
| 52 Week High | $6.39 | $6.31 |
| Indicator | IXHL | TPCS |
|---|---|---|
| Relative Strength Index (RSI) | 51.99 | 45.29 |
| Support Level | $3.10 | $5.12 |
| Resistance Level | $3.87 | $5.69 |
| Average True Range (ATR) | 0.20 | 0.21 |
| MACD | 0.00 | -0.07 |
| Stochastic Oscillator | 44.78 | 23.33 |
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
Techprecision Corp manufactures precision, large-scale fabricated and machined metal structural components and systems. The company provides end-to-end services, transforming raw materials into precision finished products through custom fabrication, precision machining, assembly, integration, inspection, non-destructive evaluation, and testing. It manufactures products in accordance with customers' drawings and specifications while complying with applicable national and international industry codes and standards. Its segments are: Ranor, which generates the majority of revenue, and Stadco, both focused on the manufacture and assembly of components mainly for defense and other precision industrial customers.